Statin rx may prevent myocardial ischemia-reperfusion injury

Statin rx may prevent myocardial ischemia-reperfusion injury

(HealthDay)—Postconditioning with rosuvastatin prevents myocardial ischemia-reperfusion injury in a rat model, according to a study published online Aug. 31 in Cardiovascular Therapeutics.

Chun-Wei Liu, from Tianjin Medical University in China, and colleagues examined whether postconditioning with rosuvastatin could reduce myocardial ischemia-reperfusion injury. In the presence and absence of rosuvastatin, isolated rat hearts underwent 30 minutes of ischemia and 60 minutes of reperfusion.

The researchers found that myocardial infarct size was reduced significantly and cardiac function improved with rosuvastatin at 5 and 10 nM. At higher concentrations, protection disappeared; increased damage was seen at 50 nM. Rosuvastatin increased the phosphorylation of B (Akt) and glycogen synthase kinase-3β (GSK-3β) at 5 nM, in parallel with an increased Ca2+ load required to open the mitochondrial permeability transition pore (mPTP). Superoxide dismutase activity was increased significantly and malondialdehyde and radical oxygen species levels were decreased with rosuvastatin postconditioning. These protective effects were abolished with LY294002 phosphatidylinositol-3-kinase (PI3K) inhibitors.

"Rosuvastatin prevents myocardial ischemia-reperfusion by inducing phosphorylation of PI3K-Akt and GSK-3β, preventing oxidative stress and subsequent inhibition of mPTP opening," the authors write.

Explore further

LDL reduction in hypertriglyceridemia varies per statin

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2016 HealthDay. All rights reserved.

Citation: Statin rx may prevent myocardial ischemia-reperfusion injury (2016, September 12) retrieved 15 September 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more